CAMARDA, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 3.087
EU - Europa 664
AS - Asia 563
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 4.322
Nazione #
US - Stati Uniti d'America 3.072
CN - Cina 278
UA - Ucraina 167
DE - Germania 147
SG - Singapore 133
TR - Turchia 116
GB - Regno Unito 105
IT - Italia 104
FI - Finlandia 56
SE - Svezia 46
VN - Vietnam 27
CA - Canada 15
BE - Belgio 9
FR - Francia 9
NL - Olanda 6
LT - Lituania 4
RU - Federazione Russa 4
IN - India 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
IR - Iran 2
PL - Polonia 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
EC - Ecuador 1
HK - Hong Kong 1
IE - Irlanda 1
LU - Lussemburgo 1
NP - Nepal 1
ZA - Sudafrica 1
Totale 4.322
Città #
Fairfield 475
Woodbridge 431
Houston 245
Jacksonville 188
Ashburn 186
Seattle 175
Chandler 173
Cambridge 161
Ann Arbor 139
Wilmington 136
Singapore 111
Santa Clara 67
Nanjing 64
Izmir 62
Beijing 51
San Diego 47
New York 44
Milan 40
Princeton 40
Boardman 33
Shanghai 32
Munich 31
Dong Ket 26
Dearborn 22
Bremen 20
Ferrara 20
Helsinki 20
Addison 16
Hebei 16
Mcallen 16
Shenyang 16
Nanchang 13
Auburn Hills 12
Montréal 12
Changsha 10
Brussels 9
Norwalk 9
Philadelphia 9
Los Angeles 8
Jiaxing 7
Jinan 7
Ningbo 7
Tianjin 7
London 6
Mountain View 6
Falls Church 5
Indiana 5
Tappahannock 5
Amsterdam 4
Padova 4
Redwood City 4
San Mateo 4
Frankfurt am Main 3
Guangzhou 3
Kunming 3
Orange 3
Redmond 3
Taizhou 3
Toronto 3
Verona 3
Zhengzhou 3
Acton 2
Augusta 2
Aurora 2
Bologna 2
Des Moines 2
Hefei 2
Hounslow 2
Jakarta 2
Lanzhou 2
Lodz 2
Messina 2
Monmouth Junction 2
Prescot 2
Rome 2
San Francisco 2
Scorzè 2
Wandsworth 2
Washington 2
Ardabil 1
Boston 1
Brno 1
Buffalo 1
Chicago 1
Chiswick 1
Collecorvino 1
Colleferro 1
College Station 1
Dublin 1
Düsseldorf 1
Espoo 1
Falkenstein 1
Fuzhou 1
Hanoi 1
Hendon 1
Islington 1
Kilburn 1
La Canada Flintridge 1
Las Vegas 1
Leawood 1
Totale 3.340
Nome #
Chimeric G proteins in fluorimetric calcium assays: Experience with opioid receptors 244
null 205
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 150
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 144
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 138
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 137
A new ligand for the urotensin II receptor 133
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 129
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 123
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 119
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 118
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 118
Structure-activity study at positions 3 and 4 of human neuropeptide S. 116
Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle 114
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 113
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 112
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 111
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 111
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 110
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 109
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 108
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 108
The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems 108
Pharmacological characterisation of novel kinin B2 receptor ligands 107
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. 105
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 104
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 101
Structure-activity relationship study on human urotensin II 101
Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors 99
Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol. 95
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Galpha(qi5). 94
null 94
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 88
null 87
null 78
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS. 73
Synthesis and Structure-Activity Relationships of (-)-cis-N-Normetazocine-Based LP1 Derivatives 72
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 32
Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-Cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4). 30
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 19
Totale 4.357
Categoria #
all - tutte 18.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 619
Totale 19.260


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020663 0 0 0 0 84 123 98 104 86 94 51 23
2020/2021580 48 62 26 91 23 50 31 62 13 59 61 54
2021/2022456 17 52 54 5 31 14 31 26 13 41 41 131
2022/2023439 43 26 15 51 79 59 34 35 56 1 21 19
2023/2024266 21 32 15 8 8 59 11 21 3 4 16 68
2024/2025286 35 27 105 23 96 0 0 0 0 0 0 0
Totale 4.357